Icon recieves external financial support for groundbreaking decentralized clinical trial technology
With the world's explosive growth into digital and remote medicine during the COVID-19 pandemic, Icon is looking into ways to apply the same remote capabilities to make medicine creation clinical trials faster, cheaper and more diverse. As of 2022, Icon expects to implement virtual check-ins for patients, file consent forms online and automate data collection with trial-provided wearables / sensors. Enterprise Ireland has comitted €4 million in R&D support to accelerate the project to enhahnce this project and the backend data systems required to put it all together.
Balance Sheet|Discontinued ActivityIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.